[Butylon in pancreatitis and subcutaneous necrosis].
D000273:Adipose Tissue; D000632:Aminopyrine / Q000628:therapy*; D002110:Caffeine; D004194:Disease; D004338:Drug Combinations; D009525:Niacin / Q000628:therapy*; D009539:Nicotinic Acids; D010195:Pancreatitis / Q000628:therapy*; D010628:Phenetidine / Q000031:analogs & derivatives; D011343:Procaine / Q000628:therapy*; D012457:Salicylamides; D012980:Sodium Salicylate / Q000628:therapy*; D013831:Thiamine / Q000031:analogs & derivatives
D004338:Drug Combinations; D009539:Nicotinic Acids; D012457:Salicylamides; C023636:bucetin, caffeine, dibenzoylthiamine, ethenzamide drug combination; D000632:Aminopyrine; D010628:Phenetidine; D009525:Niacin; D002110:Caffeine; D011343:Procaine; D012980:Sodium Salicylate; D013831:Thiamine
ADIPOSE TISSUE/diseases; AMINOPYRINE/therapy; NICOTINIC ACID/therapy; PANCREATITIS/therapy; PROCAINE/therapy; SODIUM SALICYLATE/therapy